Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

Clinical trial NCT07486960 · RECRUITING

Trial details

NCT number: NCT07486960
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2026-04-20
Primary completion: 2027-08-13
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.